ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,972Medicare Part D Prescriptions Filled, Including Refills

Rank: 299 out of 1844

$594K Total Retail Price of All Prescriptions

Rank: 235 out of 1844

558 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,822 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 340 241 1 1
SIMVASTATIN 323 251 2 3
HYDROCODONE-ACETAMINOPHEN 315 191 S3 3 2
LISINOPRIL 282 230 4 4
OMEPRAZOLE 269 217 5 5
METFORMIN HCL 241 214 6 8
ZOLPIDEM TARTRATE 181 128 7 23
FUROSEMIDE 177 136 8 7
METOPROLOL SUCCINATE 153 137 9 14
METOPROLOL TARTRATE 137 118 10 11
MELOXICAM 135 92 11 28
CITALOPRAM HBR 133 96 12 19
GABAPENTIN 129 89 13 15
AMLODIPINE BESYLATE 128 115 14 6
NEXIUM 126 92 15 31
ADVAIR DISKUS 108 89 16 51
SERTRALINE HCL 107 85 17 21
ATORVASTATIN CALCIUM 92 68 18 12
ATENOLOL 89 82 19 17
TRAMADOL HCL 85 63 20 18
PREDNISONE 83 49 21 40
TRIAMTERENE-HCTZ 81 75 22 48
LANTUS SOLOSTAR 81 68 22 97
NIFEDIPINE ER 80 73 24 154
GLIMEPIRIDE 80 80 24 35
PROAIR HFA 79 70 26 45
SYMBICORT 74 55 27 134
DIOVAN HCT 72 67 28 96
ESCITALOPRAM OXALATE 70 41 29 52
LYRICA 70 44 29 92
CYMBALTA 69 43 31 36
TAMSULOSIN HCL 69 58 31 27
HYDROCHLOROTHIAZIDE 68 52 33 9
BUPROPION XL 67 43 34 190
PRAVASTATIN SODIUM 65 51 35 10
SYNTHROID 64 62 36 55
FLUOXETINE HCL 63 46 37 41
LOSARTAN-HYDROCHLOROTHIAZIDE 61 61 38 47
DIOVAN 61 38 38 58
DICLOFENAC SODIUM 56 31 40 122
ALENDRONATE SODIUM 54 42 41 25
LANTUS 52 41 42 42
SPIRIVA 52 38 42 57
CLONIDINE HCL 51 39 44 64
JANUVIA 51 51 44 77
PEN NEEDLE 51 49 44 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.